Manitoba patients suffering from multiple sclerosis will soon be able to take part in liberation therapy for their illness without incurring the cost of travelling half way around the world.
The Manitoba government has announced a partnership with Saskatchewan to perform clinical trials at a cost of $5 million towards research on the potential relationship between multiple sclerosis and chronic cerebro-spinal venous insufficiency (CCSVI).
“Manitobans and Canadians living with MS are pleased that the Manitoba government has made multiple sclerosis a top-priority health issue”, said MS Society of Canada, Manitoba Division president Wendy O’Malley. “Manitobans and Canadians who are affected by MS deserve answers as quickly as possible on this research.”
MS advocates and patients have long been pressuring the government to adopt the treatments in Manitoba, which have previously been made available in other Canadian provinces.
The funding will be made available to the Manitoba Health Research Council (MHRC).